CHDH and neoplasm: Conclusions: Our study is the first to demonstrate a strategy to reprogram the glycine, serine, and threonine metabolic pathways via the CuO nanoparticle-mediated downregulation of choline dehydrogenase (Chdh) in tumor tissues.